Ryon P. Graf

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

Howard I. Scher, David Lu, Nicole A. Schreiber et al. · JAMA Oncology · 2016 · 637 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer

Karen A. Autio, Robert Dreicer, Justine Anderson et al. · JAMA Oncology · 2018 · 253 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber et al. · JAMA Oncology · 2018 · 238 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study

Zachery R. Reichert, Todd M. Morgan, Gerald Li et al. · Annals of Oncology · 2022 · 201 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

Hanna Tukachinsky, Russell W. Madison, Jon Chung et al. · Clinical Cancer Research · 2021 · 194 citations · Full text

Medicine, Molecular Genetics, Oncology +17